Premium
FIRST‐LINE L‐ASPARAGINASE‐BASED CHEMOTHERAPY PLUS RADIOTHERAPY IS ACTIVE IN STAGE I/II EXTRANODAL NK/T‐CELL LYMPHOMA: RESULTS FROM PEKING UNIVERSITY CANCER HOSPITAL
Author(s) -
Song Y.,
Jia J.,
Wu M.,
Leng X.,
Lin N.,
Xie Y.,
Zheng W.,
Wang X.,
Ping L.,
Tu M.,
Ying Z.,
Zhang C.,
Liu W.,
Deng L.,
Zhu J.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2437_113
Subject(s) - medicine , chop , vincristine , chemotherapy , gemcitabine , gastroenterology , etoposide , regimen , radiation therapy , asparaginase , carboplatin , lymphoma , surgery , chemotherapy regimen , prednisolone , oncology , cisplatin , cyclophosphamide , leukemia , lymphoblastic leukemia